22.06.2017
- US drug development company Parexel International is being acquired by private equity group Pamplona Capital Management in a deal valued at approximately $5 billion, including debt...
13.01.2011
- Merck & Co struck an alliance with contract researcher Parexel International to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called...